Glenn Rockman

Glenn Rockman is the Founder and Managing Partner of Adjuvant Capital, a life sciences investment company focused on addressing public health challenges through innovative technologies. In addition to this role, Rockman serves as a Director for multiple organizations, including VitriVax, which specializes in novel vaccine formulation methods, WaterEquity, aimed at improving access to safe water and sanitation, Codagenix, Inc., which develops live-attenuated vaccines, and UNIVERCELLS. Rockman also holds Director positions at the RIGHT Fund, promoting global health technology, and previously at X-Vax Technology, Inc. and InDevR, Inc., among others. Rockman has a BA from Princeton University and studied Mandarin and Politics at The Chinese University of Hong Kong.